Drug Profile
Pertussis acellular vaccine - Chiron
Alternative Names: AcelluvaxLatest Information Update: 03 May 2006
Price :
$50
*
At a glance
- Originator Chiron
- Class Bacterial vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Market Withdrawal Pertussis
Most Recent Events
- 20 Apr 2006 Chiron Corporation has been acquired and merged into Novartis
- 01 Jan 2002 Withdrawn for Pertussis in Italy (Injection)
- 01 Jan 2002 Withdrawn for Pertussis in Thailand (Injection)